塔格糖市場 - 預測 2026-2031

預計到 2025 年，塔格糖市場規模將達到 203,765,000 美元，到 2031 年將達到 282,668,000 美元，年複合成長率為 5.61%。

由於其獨特的特性——攝入後不會升高血糖值，塔格糖作為一種極具潛力的糖尿病患者專用食品成分而備受關注。美國食品藥物管理局(FDA) 已授予其 GRAS（公認安全）認證，正式批准其作為甜味劑用於各種食品和飲料。除了作為甜味劑的效用外，塔格糖還與多種健康益處有關，包括降低齲齒風險、改善腸道健康和降低心臟病風險。塔格糖市場主要由粉末和液體兩種形式構成，為生產商提供了多樣化的選擇，並滿足了食品和飲料行業的各種應用需求。

市場促進因素

糖尿病盛行率的不斷上升是推動塔格糖成長要素。初步的人體研究表明，塔格糖能夠降低餐後血糖值和胰島素反應。糖尿病流行是一個全球性的健康問題，在主要國家都有較高的盛行率。鑑於塔格糖具有替代傳統糖的潛力，且已被證實對血糖反應有益，因此它已成為市場上一個值得關注的選擇，尤其適用於那些尋求糖尿病和糖尿病前期飲食管理方案的人。

人們對D-塔格糖健康益處的認知不斷提高，推動了市場擴張。由於擔心現代藥物的潛在副作用，消費者越來越意識到將D-塔格糖融入日常生活所帶來的益處。美國食品藥物管理局（FDA）認可其促進健康的特性，已核准D-塔格糖作為一種稀有醣類，具有廣泛的健康益處。這些益處包括改善血糖控制、降低心血管疾病風險、減少齲齒易感性、改善腸道健康。大量人體和動物研究證實了D-塔格糖攝取的安全性，迄今尚未報告任何不良反應。值得注意的是，D-塔格糖在韓國、澳洲和紐西蘭等國家被用作通用甜味劑，這有助於提高全球對其的認知度和需求。

市場挑戰

儘管塔格糖市場潛力巨大，但由於其供應有限以及生產過程中涉及複雜的酶促反應，市場仍面臨許多挑戰。目前，與其他甜味劑相比，塔格糖價格相對較高，這主要是由於其萃取過程複雜。從乳糖中提取塔格糖需要特殊的、多步驟的工藝，這顯著增加了其生產成本。此外，塔格糖生產主要依賴乳糖作為原料，因此極易受到乳製品市場波動和供應鏈中斷的影響。這些因素可能導致生產者難以獲得穩定的塔格糖供應，影響塔格糖在各種產品中的應用，並限制其更廣泛的市場推廣。

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

第5章 按應用程式分類的塔格糖市場

• 介紹
• 食品/飲料
• 製藥
• 其他

第6章 依形式分類的塔格糖市場

• 介紹
• 粉末
• 液體

第7章 按分銷管道分類的塔格糖市場

• 介紹
• 線上
• 離線

第8章：塔格托斯市場區域分類

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第10章：公司簡介

• Bonumose, Inc.
• Damhert Nutrition NV
• Linlu Biotechnology Co., Ltd.
• Anhui Hegeng Biotech Engineering
• Wuxi Jcantek Pharmaceuticals
• Syngars Technology
• Henan Yihengyuan Biotechnology
• Zhejiang Yixin Pharmaceutical Co., Ltd.
• Huaxu Pharmaceutical
• Glentham Life Sciences
• Clearsynth Labs
• GLR Innovations
• Inalco SpA
• HSF Biotech
• Hebei Runxuchen Trading Co., Ltd.

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

Tagatose Market is projected to increase at a 5.61% CAGR, growing from USD 203.765 million in 2025 to USD 282.668 million in 2031.

Tagatose emerges as an appealing ingredient for inclusion in specialized foods for individuals with diabetes due to its unique characteristic of not causing increases in glucose blood levels upon consumption. Granted GRAS (Generally Recognized As Safe) status by the U.S. Food and Drug Administration (FDA), tagatose is officially recognized for use as a sweetener in various food and beverage products. Beyond its utility as a sweetener, tagatose has been associated with various health benefits, including reduced risk of tooth decay, improvements in gut health, and decreased risk of heart disease. The tagatose market is characterized by two primary forms-powder and liquid-offering versatility to manufacturers and catering to diverse application needs within the food and beverage industry.

Market Drivers

The rising number of diabetic cases represents a primary growth catalyst. Preliminary human studies have indicated that tagatose exhibits low postprandial blood glucose and insulin response. The prevalence of diabetes is a global health concern, with significant numbers reported in major nations. Given its potential as an alternative to traditional sugar and its demonstrated benefits in glycemic response, tagatose emerges as a noteworthy contender in the market, particularly for individuals seeking dietary management solutions for diabetes and prediabetic conditions.

Rising awareness about health benefits of tagatose is driving market expansion. Consumers are becoming more conscious of potential advantages of incorporating d-tagatose into their lifestyles, driven by concerns about potential side effects of modern therapeutic agents. Recognizing its health-promoting properties, the FDA acknowledges d-tagatose as a rare sugar offering a spectrum of health benefits. These benefits include enhanced glycemic control, reduced risk of cardiovascular disease, lowered susceptibility to tooth decay, and improvements in gut health. Numerous human and animal studies support the safety of d-tagatose consumption, with no adverse effects reported to date. Notably, d-tagatose serves as a general-purpose sweetener in countries such as Korea, Australia, and New Zealand, contributing to its increased awareness and demand globally.

Market Challenges

Despite promising potential, the tagatose market encounters several challenges stemming from limited availability and the intricate enzymatic process involved in its production. Currently, tagatose is relatively more expensive compared to other sweeteners due to complexity of its extraction process. The specialized and multi-step procedures required to extract tagatose from lactose contribute significantly to its production cost. Moreover, reliance on lactose as the primary raw material for tagatose production introduces vulnerability to fluctuations in dairy markets and potential disruptions in the supply chain. These factors pose challenges to consistent availability of tagatose for manufacturers, potentially impacting feasibility of incorporating tagatose into various products and limiting broader market adoption.

Market Segmentation

By application, the tagatose market is categorized into food and beverages, pharmaceuticals, and other sectors. Within the food and beverage domain, tagatose has gained popularity as a sought-after alternative to sugar, finding widespread use in variety of food and beverage products. In the pharmaceutical arena, tagatose is undergoing exploration as a potential ingredient in diabetic medications and oral care products. This interest is fueled by its distinguished attributes, including low glycemic index and prebiotic properties. Beyond these primary segments, tagatose finds utility in other categories as well. It may be incorporated into certain cosmetic products where its humectant properties can be beneficial. Additionally, tagatose's presence in some dietary supplements is notable, particularly in the role of a prebiotic, demonstrating its versatility across multiple application areas.

Regional Analysis

North America is projected to account for notable market share, reflecting the region's growing consumer preference for healthy and clean-label products featuring natural ingredients. This shift in consumer behavior aligns seamlessly with the intrinsic appeal of tagatose, known for its low-calorie and low-glycemic properties. Companies have achieved significant regulatory and food application milestones in both the United States and Canada. The advancement of commercial production facilities underscores the industry's commitment to advancing the use of tagatose, a rare sugar, in various food applications, positioning North America as a key market driver.

Product Specifications

Leading manufacturers and distributors provide high-quality tagatose products that consistently meet or exceed grade requirements and specifications. L-Tagatose products feature molecular formula C6H12O6 with molecular weight of 180.16, maintaining rigorous quality standards. D-Tagatose products, including specialized variants, boast high purity levels of 97-98%, adhering to stringent specifications and quality standards. These substances are characterized by specific molecular weights and formulas, with optimal storage conditions recommended in inert atmospheres at room temperature.

D-tagatose is available as white crystalline powder exhibiting specific boiling points and flash points, with defined density and predicted pKa values. Products are soluble in water and intended for various applications. Manufacturers provide comprehensive ranges of products and services, positioning themselves as trusted sources of research materials and fine chemicals in the scientific and food industry communities, supporting continued market development and application expansion.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Tagatose Market Segmentation

By Application

• Food And Beverages
• Pharmaceutical
• Others

By Form

• Powder
• Liquid

By Distribution Channel

• Online
• Offline

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. TAGATOSE MARKET BY APPLICATION

• 5.1. Introduction
• 5.2. Food And Beverages
• 5.3. Pharmaceutical
• 5.4. Others

6. TAGATOSE MARKET BY FORM

• 6.1. Introduction
• 6.2. Powder
• 6.3. Liquid

7. TAGATOSE MARKET BY DISTRIBUTION CHANNEL

• 7.1. Introduction
• 7.2. Online
• 7.3. Offline

8. TAGATOSE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Bonumose, Inc.
• 10.2. Damhert Nutrition NV
• 10.3. Linlu Biotechnology Co., Ltd.
• 10.4. Anhui Hegeng Biotech Engineering
• 10.5. Wuxi Jcantek Pharmaceuticals
• 10.6. Syngars Technology
• 10.7. Henan Yihengyuan Biotechnology
• 10.8. Zhejiang Yixin Pharmaceutical Co., Ltd.
• 10.9. Huaxu Pharmaceutical
• 10.10. Glentham Life Sciences
• 10.11. Clearsynth Labs
• 10.12. GLR Innovations
• 10.13. Inalco SpA
• 10.14. HSF Biotech
• 10.15. Hebei Runxuchen Trading Co., Ltd.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations